NEW YORK, Oct. 12, 2011 /PRNewswire/ -- StriVectin®, the clinical anti-aging expert, was one of three honorees to receive The Skin Cancer Foundation's 2011 Skin Sense Award Tuesday night at The Plaza. The award, presented at the Foundation's annual gala, honors exceptional achievement in skin health. The company was recognized for its exclusive NIA-114™ molecule, a multi-patented, proprietary technology rooted in 30 years of research into DNA repair and skin cancer prevention. Bringing a new level of medical research and rigor to skin care, StriVectin's NIA-114™ technology yields exceptional anti-aging and skin repair results and is clinically proven to reverse the visible effects of skin damage over time.
"Our mission is to repair and rebuild healthy skin layers, because our belief is that healthy skin is truly the most beautiful skin," said Melisse Shaban, CEO of StriVectin, in accepting the award. "StriVectin is immensely proud to be bringing these discoveries to the world in unique and novel ways, and we are committed to supporting The Skin Cancer Foundation and the important work they do in the areas of awareness and research."
About StriVectin's Technology:
The development of StriVectin's exclusive Niacin (Vitamin B3) molecule called NIA-114™ is the result of over 30 years of research by Drs. Myron and Elaine Jacobson, noted biochemists, and members of the Arizona Cancer Center. It all started with their studies on the mechanisms by which cells naturally avoid the development of skin cancer that led to their findings that niacin has many functions in skin cells. Over many years, including research partially funded by the National Institutes of Health, they continued to study how niacin is involved in how cells respond to DNA damage.
With more than 14 clinical studies involving 600 subjects and 57 global patents, its unique and unrivaled mechanisms of benefit to skin, its superb safety and tolerability with no side effects, and its compatibility with other potent skin care actives, NIA-114™ is poised to be a dominant skin care technology for years to come. In fact, NIA-114™ is so effective it has been chosen by the National Cancer Institute for further study as a possible skin cancer prevention agent.
StriVectin products are available at department store and specialty retailers nationwide, and at strivectin.com.
About The Skin Cancer Foundation
The Skin Cancer Foundation is the only global organization solely devoted to the prevention, early detection and treatment of skin cancer. The mission of the Foundation is to decrease the incidence of skin cancer through public and professional education and research. For more information, visit www.SkinCancer.org.
StriVectin® is the largest independent prestige skin care company, focusing on clinical anti-aging skin care solutions. Backed by science and rigorous clinical validation, StriVectin is at the forefront of skin care technology and product innovation. Its unique dual-use repair cream StriVectin-SDTM Intensive Concentrate for Stretch Marks and Wrinkles is a best-seller around the world, and is often credited with starting the clinical cosmeceutical skin care category. StriVectin products are sold through department stores and specialty retailers in North America, Europe, the Middle East and Asia. The company maintains corporate offices in New York, NY, and Raleigh, NC, and research facilities in Tucson, AZ. For more information, visit strivectin.com